# Institutional short selling of LANXESS

> Live situation record from CLSTR: https://clstr.news/situations/institutional-short-selling-of-lanxess
> Updated: 2026-08-16T04:00:00.000Z. Sources: 4. Developments: 2.

Institutional investors have been steadily increasing their short positions in the German company LANXESS.

In July 2026, LANXESS shares saw a modest rise to €15.39 despite Bridgewater Associates increasing its net short position from 0.49% to 0.53% of the free float. At that time, BlackRock Investment Management (UK) led other institutional short holders with a 2.35% stake. This activity followed a period of decline for the stock, which had recently reported a revenue decline of 13.9% and a loss of €1.63 per share.

By mid-August 2026, Bridgewater Associates further expanded its net short position from 0.61% to 0.70%. During this same period, BlackRock’s presence in the short side of the stock was noted through various entities, including BlackRock Investment Management (UK) Limited holding a 1.94% position.

## Timeline

### 2026-08-16: Carl Zeiss Meditec implements cost-cutting measures amid declining revenue

Carl Zeiss Meditec is implementing a ‘ProfitUp’ program to cut costs by €200 million and reduce staff by up to 700, amid declining revenues and increased short-selling from firms like Citadel and Millennium.

4 sources. https://clstr.news/cluster/institutional-short-positions-target-sma-solar-and-lanxess

### 2026-07-22: LANXESS shares rise modestly as Bridgewater expands short position

LANXESS stock rose 0.92% to €15.39 as Bridgewater lifted its short stake to 0.53%, joining other funds with sizable shorts; the share stays well below its 52‑week high amid recent losses.

3 sources. https://clstr.news/cluster/lanxess-shares-rise-modestly-as-bridgewater-expands-short-position

---
Cite as: Institutional short selling of LANXESS. CLSTR, https://clstr.news/situations/institutional-short-selling-of-lanxess